Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Baum

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Nuclear Medicine Communications|March 24, 1999
Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancerM Lacić, T Bokulić, J Lukac, et al.
Nuclear Medicine Communications|May 1, 1989
99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical resultsR P Baum, A Hertel, M Lorenz, et al.
The International Journal of Biological Markers|October 1, 1996
Generation of human monoclonal anti-idiotypic antibodies with specificity to the murine monoclonal anti-CA 125 antibody B43.13J B Oltrogge, B Donnerstag, R P Baum, et al.
Hybridoma|February 1, 1997
OVAREX MAb-B43.13:IFN-gamma could improve the ovarian tumor cell sensitivity to CA125-specific allogenic cytotoxic T cellsR Madiyalakan, R Yang, B C Schultes, et al.
The International Journal of Biological Markers|January 1, 1997
How to overcome the disturbing effects of human anti-mouse antibodies (HAMA) on in vitro assaysJ B Oltrogge, R P Baum, K N Lema, et al.
Pneumologie (Stuttgart, Germany)|January 18, 2012
[Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system]D Hörsch, Y Sayeg, R Bonnet, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1998
Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1)B C Schultes, R P Baum, A Niesen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Direct labeling of monoclonal antibodies with technetium-99m by photoactivationT R Sykes, T K Woo, R P Baum, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEAA Hertel, R P Baum, M Lorenz, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferaseP Fischer, R P Baum, M Tauber, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Nuclear Medicine Communications|March 24, 1999
Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancerM Lacić, T Bokulić, J Lukac, et al.
Nuclear Medicine Communications|May 1, 1989
99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical resultsR P Baum, A Hertel, M Lorenz, et al.
The International Journal of Biological Markers|October 1, 1996
Generation of human monoclonal anti-idiotypic antibodies with specificity to the murine monoclonal anti-CA 125 antibody B43.13J B Oltrogge, B Donnerstag, R P Baum, et al.
Hybridoma|February 1, 1997
OVAREX MAb-B43.13:IFN-gamma could improve the ovarian tumor cell sensitivity to CA125-specific allogenic cytotoxic T cellsR Madiyalakan, R Yang, B C Schultes, et al.
The International Journal of Biological Markers|January 1, 1997
How to overcome the disturbing effects of human anti-mouse antibodies (HAMA) on in vitro assaysJ B Oltrogge, R P Baum, K N Lema, et al.
Pneumologie (Stuttgart, Germany)|January 18, 2012
[Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system]D Hörsch, Y Sayeg, R Bonnet, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 1998
Anti-idiotype induction therapy: anti-CA125 antibodies (Ab3) mediated tumor killing in patients treated with Ovarex mAb B43.13 (Ab1)B C Schultes, R P Baum, A Niesen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1995
Direct labeling of monoclonal antibodies with technetium-99m by photoactivationT R Sykes, T K Woo, R P Baum, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEAA Hertel, R P Baum, M Lorenz, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferaseP Fischer, R P Baum, M Tauber, et al.
Pageof 14